Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Once the news SPREADS, we will hit NEW HIGHS!! (.069+)
Last time we ran from .018 to .069!! THIS NEWS IS 10x's BETTER!!
Hang on people!! Watch what happens this week!!
$VDRM
THIS A MASSIVE!!!!
ViaDerma Receives Provisional Patent Numbers for Its FDA Registered Viabecline and Cannabis Technologies, and Seeks to Distribute its Products with a Management, Marketing and Distribution Company in Canada to Approved International Cannabis Countries
The Company will Target Countries where Medical and Recreational Cannabis Sales are Legal and Accepted and Scientific Research is Allowed
LOS ANGELES, CA--(Marketwired - March 20, 2017) - ViaDerma, Inc. (OTC PINK: VDRM), a specialty pharmaceutical company devoted to bringing new products to market, recently announced today that the President, Dr. Christopher Otiko has received the Provisional Patent number for two patents pending. The Cannabis Provisional Patent #62466209, a patent for delivering medical marijuana /cannabis to the body by applying the medication onto the skin in an ointment base topical solution. The second provisional patent #62433964 for enhanced antibiotic and drug delivery for "Aqueous Topical Applications" for human and veterinarian uses. The Company plans to continue to expand its (IP) "Intellectual Property Portfolio" in 2017.
The Company has signed a LOI or letter of intent to work with a Canadian-based investment group with expertise in logistics that includes distribution for the new and anticipated products. The investment group will target sales for the new patent pending products to countries that have accepted "Medical Marijuana" and "Recreational Use" of cannabis products and technologies for delivery of CBD and THC. This group will also target countries that allow the "Clinical Studies" for medical testing such as the United Kingdom and other Asian countries.
Company CEO Dr. Christopher Otiko is attending the Diabetic Foot Global Conference (DFCon 20017), at Baylor College of Medicine in Houston, Texas and on Friday 24th of March will present a poster abstract based on seven years of research treating patients with Viabecline. "In recent studies, Viabecline has been more than 96% effective in healing diabetic foot ulcers within 4 weeks. This effect is more pronounced in more severe wounds, and the effect is the same whether the wound is infected or not," said Dr. Otiko. "Our goal is to have Viabecline added to all diabetic foot ulcer treatment protocols."
"We are also continuing the clinical testing stages of an anti-aging topical solution, a topical pain medication, a topical for male-pattern baldness, and a topical designed to boost male libido. The market for our many products is very promising. We are enthusiastic about the results we have achieved to date in terms of the anecdotal feedback we have received from the medical community," said Dr. Otiko.
About ViaDerma, Inc.
ViaDerma, Inc. (OTC PINK: VDRM) is a publicly traded specialty pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas. ViaDerma's lead product, Viabecline, uses an innovative transdermal delivery method that allows for application of active ingredients in a topical form. This patent-pending dual carrier transdermal technology may be applied in products within the medical and cosmetic markets. Also, a patent application using the combination of CBD and THC with the delivery system was filed in 2017. The use of CBD is aimed at the reduction of inflammation and for the treatment of several diseases, such as, nicotine addiction, fibromyalgia, Cohn's disease, schizophrenia, migraine headaches, pain management for cancer and Multiple Sclerosis. For more information, please visit: www.viadermalicensing.com
Forward Looking Statements
Forward-Looking Statements certain statements in this release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be identified using words such as "anticipate," "believe," "expect," "future," "may," "will," "would," "should," "plan," "projected," "intend," and similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. The Company's future operating results are dependent upon many factors, including but not limited to the Company's ability to: (i) obtain sufficient capital or a strategic business arrangement to fund its expansion plans; (ii) build the management and human resources and infrastructure necessary to support the growth of its business; (iii) competitive factors and developments beyond the Company's control; and (iv) other risk factors. We assume no obligation to update the information contained in this news release.
Dr. Christopher Otiko
Chief Executive Officer
Email: info@viadermalicensing.com
Investor Relations Phone number: 310-734-6111
Copyright © 2017 Marketwired. All Rights Reserved
HUGE NEWS!! .10-12+ here we come!!
Hang on for the ride!
$VDRM
OVERSOLD! Bounce will happen this week with conference March 23-25
.05+ this week imo
$VDRM
$1-$3
$VDRM
~ CEO speaking at the Global Diabetic Foot Conference in Houston March 23-25, 2017 ~
http://www.marketwired.com/press-release/dr-chris-ayo-otiko-president-viaderma-inc-is-selected-write-article-healing-diabetic-otc-pink-vdrm-2194656.htm
http://dfcon.com
https://www.drugs.com/otc/676986/viabecline.html
https://www.linkedin.com/pulse/healing-diabetic-ulcers-dave-pozek-1
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129403043
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129390203
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129368069
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129334996
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129312100
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129311752
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129297007
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129296364
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129295215
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129286262
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129196331
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129040891
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128962099
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128961948
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128957163
Totally agree with you Eddyos! Great run coming!!
ViaDerma will be one of the BIGGEST runners this year!!
$VDRM
Conference this week! We should pop over .05!
Great run coming!!
Is it Monday yet??
$VDRM
Investors focus TODAY and going forward. We are going to go on an AMAZING run. Here's what's coming in the next few months. Looking forward to next week!!!
I had several discussions with the company and I believe they will deliver. Here's whats coming:
~ conference next week, will bring many news eyes on us, DOCS from around the world will be there to see the company's technology. I can't state how big this is.. http://dfcon.com
~ clarity regarding patents and licensing agreements via website with patent numbers etc as per stated by their Investors Relations dept. http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129648231
~ sales rolling out this year, 500,000 units @ $125/ in 2017 = $62,500,000 in revenues, company already has revenues.. https://www.otcmarkets.com/stock/VDRM/financials
~ MMJ licensing contracts could come with all the big companies as per PRs.. http://www.marketwired.com/press-release/viaderma-inc-looks-file-additional-patents-license-new-products-its-mmj-medical-marijuana-otc-pink-vdrm-2196107.htm
New updates will all be coming through future PRs
When these hit, I feel we will have an OW(P type run..
Sellers have already sold for those who wanted to sell. Completely OVERSOLD, check the chart:
http://stockcharts.com/h-sc/ui?s=VDRM&p=D&yr=0&mn=3&dy=0&id=p81682029007
Downside is limited now. Upside is huge! IMHO
If you want to contact the company on Monday, do so here..
Investor Relations
(310) 734 6111
info@viadermalicensing.com
Hang tight for the ride!
GLTA who invest!
$VDRM
$VDRM ~ looking forward to next week!!!
I had several discussions with the company and I believe they will deliver. Here's whats coming:
~ conference next week, will bring many news eyes on us, DOCS from around the world will be there to see the company's technology. I can't state how big this is.. http://dfcon.com
~ clarity regarding patents and licensing agreements via website with patent numbers etc as per stated by their Investors Relations dept. http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129648231
~ sales rolling out this year, 500,000 units @ $125/ in 2017 = $62,500,000 in revenues, company already has revenues.. https://www.otcmarkets.com/stock/VDRM/financials
~ MMJ licensing contracts could come with all the big companies as per PRs.. http://www.marketwired.com/press-release/viaderma-inc-looks-file-additional-patents-license-new-products-its-mmj-medical-marijuana-otc-pink-vdrm-2196107.htm
New updates will all be coming through future PRs
When these hit, I feel we will have an OW(P type run..
Sellers have already sold for those who wanted to sell. Completely OVERSOLD, check the chart:
http://stockcharts.com/h-sc/ui?s=VDRM&p=D&yr=0&mn=3&dy=0&id=p81682029007
Downside is limited now. Upside is huge! IMHO
If you want to contact the company on Monday, do so here..
Investor Relations
(310) 734 6111
info@viadermalicensing.com
Hang tight for the ride!
GLTA who invest!
$VDRM
$VDRM ~ looking forward to next week!!!
I had several discussions with the company and I believe they will deliver. Here's whats coming:
~ conference next week, will bring many news eyes on us, DOCS from around the world will be there to see the company's technology. I can't state how big this is.. http://dfcon.com
~ clarity regarding patents and licensing agreements via website with patent numbers etc as per stated by their Investors Relations dept. http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129648231
~ sales rolling out this year, 500,000 units @ $125/ in 2017 = $62,500,000 in revenues, company already has revenues.. https://www.otcmarkets.com/stock/VDRM/financials
~ MMJ licensing contracts could come with all the big companies as per PRs.. http://www.marketwired.com/press-release/viaderma-inc-looks-file-additional-patents-license-new-products-its-mmj-medical-marijuana-otc-pink-vdrm-2196107.htm
New updates will all be coming through future PRs
When these hit, I feel we will have an OW(P type run..
Sellers have already sold for those who wanted to sell. Completely OVERSOLD, check the chart:
http://stockcharts.com/h-sc/ui?s=VDRM&p=D&yr=0&mn=3&dy=0&id=p81682029007
Downside is limited now. Upside is huge! IMHO
If you want to contact the company on Monday, do so here..
Investor Relations
(310) 734 6111
info@viadermalicensing.com
Hang tight for the ride!
GLTA who invest!
$VDRM
Good things coming next week!
VDRM ~ DOCS from all over the world will hear about ViaDerma next week!
Starosolska, Joanna <Joanna.Starosolska@bcm.edu>
9:39 AM Wednesday, March 15, 2017
to me
Good morning,
Dr. Otiko has been invited to present his poster during the poster session at DFCon. This is a formal session, but it is not an exclusive speaking event.
Poster session will take place on March 24 from 11:40 am to 2:20 pm.
With kind regards,
Joanna Starosolska
Administrative Secretary
Division of Vascular Surgery
Baylor College of Medicine
One Baylor Plaza, MS 390
Houston, TX 77030
Ph: 713-798-7851
Fx: 713-798-2744
DFCon 2017
cid:image004.jpg@01D12770.3F6AF690
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
http://dfcon.com
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
February 8, 2017
~ CEO speaking at the Global Diabetic Foot Conference in Houston March 23-25, 2017 ~
http://www.marketwired.com/press-release/dr-chris-ayo-otiko-president-viaderma-inc-is-selected-write-article-healing-diabetic-otc-pink-vdrm-2194656.htm
https://www.drugs.com/otc/676986/viabecline.html
https://www.linkedin.com/pulse/healing-diabetic-ulcers-dave-pozek-1
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129403043
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129390203
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128962099
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
February 3, 2017
~ MASSIVE sales coming.. 500,000 units x $125 = $62,500,000 in 2017~
http://www.marketwired.com/press-release/viaderma-inc-targets-online-sales-wound-care-centers-distribution-companies-its-viabecline-pinksheets-vdrm-2193323.htm
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129402236
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129339194
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129286070
January 11, 2017
~Filed a patent application with the USPTO for its proprietary innovative transdermal delivery system~
http://www.marketwired.com/press-release/viaderma-incs-ceo-files-new-patent-application-signs-two-licensing-deals-locates-product-otc-pink-vdrm-2187878.htm
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129386093
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129283860
November 30, 2016
"Patent Pending Transdermal System" can deliver medications and nutrients into the body through the skin. The solution combined with FDA registered drugs can increase the absorption as much as 100 times directly to the localized treatment areas,
http://www.marketwired.com/press-release/viaderma-inc-clinical-studies-abroad-europe-middle-east-asia-show-promising-results-otc-pink-vdrm-2179850.htm
November 14, 2016
Filed Patent Pending use of its innovative transdermal system for the delivery of (CBD's) Calanoids and (THC) Tetrahydrocannabinol for the treatment of several diseases
http://www.marketwired.com/press-release/viaderma-inc-enters-mmj-medical-marijuana-industry-with-patent-pending-cbd-delivery-otc-pink-vdrm-2175498.htm
http://stockcharts.com/h-sc/ui?s=vdrm
Reversal will come
$VDRM
whatarush12 Member Level Friday, 03/17/17 04:59:09 PM
Re: None
Post # of 15724
1:35 PM (22 minutes ago)
to info, bcc: me
Hello,
I am a long time investor with ViaDerma, and plan to continue holding long term. Could you please provide me with some answers.
Will you be updating the company website to reflect:
~ all relevant and current patent application filings and patent numbers?
~ any licencing agreements you may have to sell Viabecline?
Just wanted to confirm that Dr. Otiko will be presenting at DFCon next week?
Can investors expect a PR next week if any re info?
Sincerely
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
info@viadermalicensing.com
1:43 PM (14 minutes ago)
to me
Hello
Yes we will be providing patent numbers in a PR and our website very soon. We will also be providing updates on other fronts including our latest marketing efforts.
Dr Otiko will be presenting next week. PR's will be released as developments unfold. We cannot tell investors ahead of time when news will be released. All I can say is we are working hard and making progress and expect to update shareholders very soon.
Thanks
Investor Relations
(310) 734 6111
Share Structure
Authorized Shares 400,000,000 a/o Mar 07, 2017
Outstanding Shares 321,232,603 a/o Mar 07, 2017
-Restricted 57,975,478 a/o Mar 07, 2017
-Unrestricted 263,257,125 a/o Mar 07, 2017
Held at DTC 246,331,609 a/o Mar 07, 2017
Float 222,337,825 a/o Jan 25, 2017
Trading under .025!
Will be comparable to One World. The CEO, Dr. Otiko, has filed '2' patent pending applications, one for the transdermal technology for Viabecline and the other for their technology and THC and CBD (Cannabinoids).
Further PRs to come.
Significantly oversold and undervalued
$VDRM
Where's your 'proof'? You said it yourself below..
People are better off believing PRs as they hold substance and value. Company's don't release them for the fun of it!
Neptune Friday, 03/17/17 09:00:11 PM
Re: FORU post# 15694
Post # of 15707
There are many divergent views regarding value at this time. Dilution is significant and ongoing.
I recommend not believing the news releases until the company proves the forward looking statements within them.
I gathered what I could across the past two weeks and added it to the bottom half of the iBox (section with white background). I will continue to update this information.
At this time, they operate under a non-exclusive license to manufacture and distribute an antibiotic known as Viabecline--a Phillips company product aka Diabecline. Seems Dr. Otiko added two ingredients and now calls it his own.
Read all of my sticky above..
$VDRM
Incorrect..
Share Structure
Authorized Shares 400,000,000 a/o Mar 07, 2017
Outstanding Shares 321,232,603 a/o Mar 07, 2017
-Restricted 57,975,478 a/o Mar 07, 2017
-Unrestricted 263,257,125 a/o Mar 07, 2017
Held at DTC 246,331,609 a/o Mar 07, 2017
Float 222,337,825 a/o Jan 25, 2017
3.2mill Market Cap
Comparable to One World. Chris has verified that the have '2' patent pending applications, one for the transdermal technology for Viabecline and the other for their technology and THC and CBD (Cannabinoids).
Further PRs have stated more to come.
Significantly oversold and undervalued
Share Structure
Authorized Shares 400,000,000 a/o Mar 07, 2017
Outstanding Shares 321,232,603 a/o Mar 07, 2017
-Restricted 57,975,478 a/o Mar 07, 2017
-Unrestricted 263,257,125 a/o Mar 07, 2017
Held at DTC 246,331,609 a/o Mar 07, 2017
Float 222,337,825 a/o Jan 25, 2017
3.2mill Market Cap
Comparable to One World. Chris has verified that the have '2' patent pending applications, one for the transdermal technology for Viabecline and the other for their technology and THC and CBD (Cannabinoids).
Further PRs have stated more to come.
Significantly oversold and undervalued
$VDRM
I'm sure there are so many levels behind the scenes that retail investors are unaware of.
Long term ViaDerma has a bright future.
Anyone, including myself, trying to predict the share price up or down, is only giving their opinion.
This company has incredible potential, and will be trading at multiples higher very soon!
$VDRM
Everyone can email the company if you have concerns
$VDRM
In print is better, then no one can rebuttal
$VDRM
info@viadermalicensing.com
1:43 PM (14 minutes ago)
to me
Hello
Yes we will be providing patent numbers in a PR and our website very soon. We will also be providing updates on other fronts including our latest marketing efforts.
Dr Otiko will be presenting next week. PR's will be released as developments unfold. We cannot tell investors ahead of time when news will be released. All I can say is we are working hard and making progress and expect to update shareholders very soon.
Thanks
Investor Relations
(310) 734 6111
1:35 PM (22 minutes ago)
to info, bcc: me
Hello,
I am a long time investor with ViaDerma, and plan to continue holding long term. Could you please provide me with some answers.
Will you be updating the company website to reflect:
~ all relevant and current patent application filings and patent numbers?
~ any licencing agreements you may have to sell Viabecline?
Just wanted to confirm that Dr. Otiko will be presenting at DFCon next week?
Can investors expect a PR next week if any re info?
Sincerely
stockzoom Tuesday, 03/07/17 11:08:12 AM
Re: None
Post # of 15651
Another response from Doc just now. I had asked him more details on CBD and other stuff apart, there were BS posted by people here last week to drive price down, now that's all exposed. I like that very very..soon
I have noticed lot of false information is being posted here by few people to drive price down. I wanted to hear from the company
Now all that's exposed !
Based on chart pattern, we will test 0.07 first and then make new high
There is no reason for this to be at 0.03 with similar companies OWC@P and CNB@X at 200+ million market caps with no FDA approved products
May be MM manipulated down to load shares
Looks like we are getting closer to the big PR
I was shocked by the fall of this stock while OWC@P keeps going up, both are in the same league !
stockzoom Tuesday, 03/07/17 12:15:13 PM
Re: None
Post # of 15647
Here is the latest RESPONSE from Doc, just 10 minutes ago
Lot of misinformation gets posted here, like Doc not responding etc
There you go, latest response from him related to the several posts here..
The only way to invest in OTCBB stock is you do your DD !
With PR on the way, we will get some blockbuster update
There is no reason for this stock to be at 7-8 million market cap, when OWC@P is near 200 million with no approved FDA products
It's a powerful Medical MJ + Biotech play
Invest and forget !
The float here is tiny and stock is trading at 0.04 ??? while OWC@P at 1.5 on what ?
This needs to be minimum 10-12 cents stock
period
stockzoom Thursday, 03/09/17 07:41:34 AM
Re: None
Post # of 15646
Another update for you guys..
Doc delivered what he promised in the email. That is great sign of integrity. The news is blockbuster and points to launch of the product. He had also told me they are working with multiple partners on MMJ trials using the proprietary THC/CBD delivery system, updates to follow soon...that is huge !
This is like I said
Biotech + MMJ stock
That is massive
Most stocks are pure biotech, this is combination of MMJ too
That's big for me
MMJ updates will be released shortly
This is now in the same league as OWC@P and CNB@X except deeply undervalued, add to that we also got largest disease market in the world - Diabetes
Huge !
The conf is going to bring in more investors with bigger pockets according to Doc, that's why he is setting up all the stuff related to manufacturing by hiring this guy, why do you think he is doing all this ? bring in more investors from biotech world, that's why the presentation at this premium conf DFCPN - all about diabetes.
That's the key !
There will be many PR updates ahead according to him. My guess is he will get deep pocket investors after the conf presentation and now that he has hired this guy for launch brings in huge credibility. He is planning perfectly. I invest in many biotech stocks and made ton on AC@D , EXE@L and many other stocks that started at 0.1-0.2 range , now trade at 30+
The float is extremely small - Most biotech have that kind of float !, unlike billions for many OTCBB/PINK stocks
I love this stock - perfect investment, deeply undervalued compared to the rest of the MMJ stocks like OWC@P, CN@X that trade at dollar +
Massive upside here, we are just 0.03, deeply undervalued. I see 0.2-0.3 in 3-4 months as more PR and updates come out..I am 100% confident we are getting bigger pocket investors in the game after the conf, just watch
stockzoom Wednesday, 03/08/17 09:13:12 AM
Re: None
Post # of 15643
Got another email in the evening from Doc, we should have PR soon. They are also going to create IR team now for more updates on CBD trials they will start. That is great news. This is now becoming more and more like OWCP as larger CBD trials start. Great buy and hold medical MJ play + Biotech on Diabetic foot ulcer makes it TWIN investment
Medical MJ + Biotech
The good news is Medical MJ will not be affected by current administration policies Sessions has made it clear. Money is moving out of recreational MJ stocks to medical MJ stocks
Looking forward to big news ahead very soon, we will get some CBD updates too, that' what I am interested to hear
The float here is tiny unlike other MJ stocks, that helps a lot
Minimum 20-25 cents stock if we match OWC@P, CB@IS and CNB@X current market cap valuation. This is deeply undervalued with massive upside in next few months as PR start flowing and we get more CBD trial updates as Doc told
I am more excited after doc's email's to hear about CBD trials now..I know patent means a lot. I want to know more about CBD trials progress they have made
That's going to drive the stock lot higher !
I agree GreenBrickRoad
Where's your email you keep speaking of?
$VDRM
False!
VDRM ~ ViaDerma ~ currently trading at .0238
Biotech play
Medical MJ play
Here's all the DD you need to know.
March 8, 2017
~ Sales, labeling & marketing being launched!! Industry expert hired!! ~
http://www.marketwired.com/press-release/viaderma-inc-hires-product-rollout-expert-manage-quality-control-labeling-marketing-pinksheets-vdrm-2201662.htm
~Ivan Klarich Reviews~
https://www.linkedin.com/in/ivanklarich/
Aidan Roark Makepeace
Founder/CEO at WRKPRTY
Aidan Roark worked with Ivan in different groups
I have had the privilege of working with and for Ivan on several software development and business strategy projects ranging from the start-up to the enterprise level and can say, without reservation, Ivan is amazing to work with. Ivan is a thoughtful and inspiring leader and team-builder, and an energetic, diligent, and reliable visionary in strategic planning and operations/executive management. I welcome every opportunity to work with Ivan and can wholeheartedly recommend his services, as well as those of his extensive team of associates.
Mireille Buiel
HR Lead at FindHotel
Mireille worked with Ivan but at different companies
I have worked together with Ivan as consultants at a California based FMCG manufacturing company. I got to know him as a value-based strategic thinker that keeps his eye on the long-term goal. He is able to bring teams and entrepreneurs quickly to the ‘pain points’ and find new practical solutions for their business (model) issues. I would definitely recommend him for complex organizational and commercial challenges.
John Fanaris
Co-Owner/GM/Sommelier at Rustic Kitchen
John worked with Ivan but at different companies
Preparing for growth and putting the right pieces together are crucial to success and Ivan brings the tools needed to the table. He has a non-confrontational demeanor in his analysis of your internal methodology with the uncanny knack of straight forward communication and a tell-it-like-it-is constructive advice. He is an expert at analyzing company operations and culture to develop a comprehensive strategy to reach your goals. If you are looking to take your company to the next level, Ivan is your man.
Jackie Lapin / Authors, Speakers, Get Leads, Get Booked
?? AUTHORS & SPEAKERS, GET LEADS, GET BOOKED–Book Your Own Speaking Engagements at Transformational Venues & Events
Jackie Lapin / worked with Ivan but at different companies
Ivan is one of the most brilliant forward-thinking business visionaries I've ever encountered. That skill is anchored by real world practical strategic analytics and implementation that ensures success. I want him on my team whenever I'm launching something new, improve what's already working or need to fix something that's not!
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129418493
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129409088
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129402020
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129401494
http://www.hopedance.org/home/awakenings/2920-virtual-realty-enters-the-arena-to-help-people-overcome-their-co-dependency-on-outside-approval-to-achieve-an-emotionally-free-high-performance-happy-life
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129344707
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129339497
February 15, 2017
~ Additional patents are being filed in the MMJ space! ~
http://www.marketwired.com/press-release/viaderma-inc-looks-file-additional-patents-license-new-products-its-mmj-medical-marijuana-otc-pink-vdrm-2196107.htm
http://www.thedailychronic.net/2017/68842/clinical-trial-thcv-lowers-blood-sugar-levels-in-type-2-diabetics/
http://www.thedailychronic.net/2017/69698/study-medical-cannabis-patients-reduce-their-use-of-opioids/
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129340717
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129277006
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129022846
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129017714
February 8, 2017
~ CEO speaking at the Global Diabetic Foot Conference in Houston March 23-25, 2017 ~
http://www.marketwired.com/press-release/dr-chris-ayo-otiko-president-viaderma-inc-is-selected-write-article-healing-diabetic-otc-pink-vdrm-2194656.htm
http://dfcon.com
https://www.drugs.com/otc/676986/viabecline.html
https://www.linkedin.com/pulse/healing-diabetic-ulcers-dave-pozek-1
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129403043
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129390203
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129368069
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129334996
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129312100
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129311752
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129297007
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129296364
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129295215
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129286262
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129196331
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129040891
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128962099
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128961948
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128957163
February 3, 2017
~ MASSIVE sales coming.. 500,000 units x $125 = $62,500,000 in 2017~
http://www.marketwired.com/press-release/viaderma-inc-targets-online-sales-wound-care-centers-distribution-companies-its-viabecline-pinksheets-vdrm-2193323.htm
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129402236
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129339194
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129286070
January 11, 2017
~Filed a patent application with the USPTO for its proprietary innovative transdermal delivery system~
http://www.marketwired.com/press-release/viaderma-incs-ceo-files-new-patent-application-signs-two-licensing-deals-locates-product-otc-pink-vdrm-2187878.htm
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129386093
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129283860
November 30, 2016
"Patent Pending Transdermal System" can deliver medications and nutrients into the body through the skin. The solution combined with FDA registered drugs can increase the absorption as much as 100 times directly to the localized treatment areas,
http://www.marketwired.com/press-release/viaderma-inc-clinical-studies-abroad-europe-middle-east-asia-show-promising-results-otc-pink-vdrm-2179850.htm
November 14, 2016
Filed Patent Pending use of its innovative transdermal system for the delivery of (CBD's) Calanoids and (THC) Tetrahydrocannabinol for the treatment of several diseases
http://www.marketwired.com/press-release/viaderma-inc-enters-mmj-medical-marijuana-industry-with-patent-pending-cbd-delivery-otc-pink-vdrm-2175498.htm
Current Market Cap ~ $9.5mill, March 10, 2017~
Share Structure
Authorized Shares 400,000,000 a/o Mar 07, 2017
Outstanding Shares 321,232,603 a/o Mar 07, 2017
-Restricted 57,975,478 a/o Mar 07, 2017
-Unrestricted 263,257,125 a/o Mar 07, 2017
Held at DTC 246,331,609 a/o Mar 07, 2017
Float 222,337,825 a/o Jan 25, 2017
2dollarbill ~ REPOST
just doing my part here...
Lead Product TetraStem
World’s strongest broad spectrum tetracycline-based topical antibiotic with proven results. Used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.
Very low water content and optimum (low) viscosity. Uses both a chemical AND physical kill mechanism which is advantageous over traditional antibiotics which use only a chemical kill mechanism and has a better resistance profile.
Potential Markets
ViaDerma is developing products in many fields of use, including:
Topical antibiotics- $6 billion/year
Toenail antifungal drugs- $3 billion/year
Diabetic amputations- $3 billion/year
Global acne- $3.02 billion/year
Psoriasis- $7.3 billion/year
Eczema- $2.5 billion/year
Other potential markets include burns, anti-aging/wrinkle remover cream, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. Innovative, patent pending dual carrier transdermal technology which can transform oral medication into topical products. Ability to enable active ingredients with a rapid transport direct to the site of action.
Ability to be used in any field including Sports Nutrition Supplements, Cosmetics, First Aid Products, Wound Care, and Skin Diseases like Acne, Eczema, and Psoriasis. Dual carrier liquid which can possess life enhancing technology with up to four year shelf-life. Facilitates transfer of chemicals through the stratum corneum with a diffusion constant 10,000x higher. Strong Advanced Biological Coverage (ABC) which has higher concentrations, faster penetration and is more effective than conventional antibiotics. ABC produces desirable results in ~24 hours or less compared to 5-7 days. It kills all harmful gram-positive and gram-negative bacteria that have been available for testing.
1- back in 2.25.2014 philips manufactured there last fda approval of tetrastem, its a 3 year shelf life as im able to see
2 - in 5.28.2014 VDRM started to manufacture there first fda approval of tetrastem, same 3 year shelf life
3 - now heres where it make huge sense in 3.2014 VDRM gets the rights to manufacture tetrastem from phlips....1 month after they start there first manufacture of tetrastem
4 - the 3 - 6 - 9 month studies kick in in a huge way, and now VDRM as of 1.2017 manufactures 500,000 bottles for sale,
...basically they took what worked expanded on it and said this is huger than we thought
5 - 12.2016 VDRM files for uopdated Viabecline patent - which is purely application - so that means anyone, anywhere, anytime they use tetrastem - pure play on licensing application
6 - back in 2015 rumors started that both PFE and MRK and Endo pharma were looking at VDRM
7 - 2.2017 Dr Otiko to write a paper on diabetic ulcers showing massive results - which means all roads to viabecline
articles of interest ( get them off the web )
1 - from a 2.2011 study reposted in 1.2017 paraplegic uses tetrastem with stem cells and walks again ( philips put the article out )
2 - 3.2015 onychmycosis article
3 - 11.2016 viabecline article
4 - 12.2016 diabetic ulcers study vdrm issued
5 - 12.2016 viabecline patent applied for
6 - 1.2017 vdrm 500,000 bottles manufactured for 2017 grossing 62-65M in sales
viabecline is a delivery of tetrastem - which can take any oral as well and apply to ointment application
PFE is all about viagra, now imagine a lotion for f on f , not just a pill, and youve opened a huge market in the world away of same sex...mrk is all about diabetes and with application wise they want in too, add in JNJ which bandaids work and graduate to a 1000% increase in healing and they want in too...
VDRM product is 85% cheaper and works better - Viabecline is what the entire game is all about here - application technology
PFE Viagra is a category killer but it is a pill - and a pill is a introduction internally to the blood stream which out of fear a great portion of the population will just not take, now factor in a female Viagra alternative that is topical and replace the male Viagra with the same topical and its obvious that PFE will be forced to enter some sort of licensing agreement to hold onto there market share and as well look to capitalize on the female market as well ( m on f , and f on f ) there are those that will only use topical not internal
MRK, LLY and MNKD are the diabetic market and its huge - toenail fungal market - now add on a turnaround solution they have been needing for years, to treat at home foot infections ( home care largest market globally ) and that market alone is extraordinary with multiple companies all vying to be the dominant player and VDRM having the solution to license
JNJ marketplace is wounds - the band , now graduate it to the ability to speed the process up say 10 fold to heal any scrapes scratched wounds and to hold there market-share JNJ will be forced to enter some sort of licensing deal just to hold the line or risk crippling there empire quite easily
MRK and JNJ baldness market is in a level all itself, as its a do it yourself world we live in - add a just for men/ ladies crowd solution to expand into the baldness market and make that a CVS Walgreen's etc play for direct access more licensing
without even touching on the other markets there is exceptional growth here
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
~Info on Dr. Chris Otiko, CEO of ViaDerma~
Radio interview from December 9, 2016. https://upticknewswire.com/viaderma-ceo-dr-chris-otiko-talks-active-treatments-for-diabetic-wounds/
https://www.linkedin.com/in/chris-ayo-otiko-80284b5/
https://www.linkedin.com/pulse/healing-diabetic-ulcers-viabecline-new-topical-antibiotic-otiko
https://www.barbadostoday.bb/2014/07/05/miracle-drug-for-diabetics/
http://www.neurogenx.com/testimonial/christopher-otiko-dpm-ceo-executive-medical-director/
https://www.ratemds.com/doctor-ratings/2334438/Dr-Christopher+A.-Otiko-Reseda-CA.html
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129394138
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129356678
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129353170
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129346970
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129340283
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129311397
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129294386
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129283754
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129265204
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129223612
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129222563
~Patent/Licensing/Manufacturing Info~
https://www.drugs.com/otc/129916/tetrastem.html
(licensed as Diabecline and Viabecline). Regardless of who owns or has the rights to the patent, ViaDerma has licensing rights, and has filed a new patent pending application for the transdermal system as per January 11, 2017 PR
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129289616
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129282983
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129282283
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129280927
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129279832
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129273942
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129273861
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129234169
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129232328
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129224588
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129224450
investorshub.advfn.com/boards/read_msg.aspx?message_id=129224065
Interesting posts!
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129413941
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129397880
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129394039
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129392467
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129386665
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129383996
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129357204
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129351881
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129346142
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129334810
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129329694
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129308249
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129278022
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129268497
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129200839
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129127030
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129126891
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129022830
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129011372
GLTA
LONG $VDRM
http://stockcharts.com/h-sc/ui?s=vdrm
Reversal will come
$VDRM
Totally agree with you! Great things coming.
Hold tight, we are significantly OVERSOLD
Reversal will happen.
$VDRM
Pstats Member Level Thursday, 03/16/17 12:36:29 PM
Re: None
Post # of 15545
1pm charts for VDRM indicating a buying frenzy
Should be over .032 by now if ETRF stupid block
VDRM ~ DOCS from all over the world will hear about ViaDerma!
Starosolska, Joanna <Joanna.Starosolska@bcm.edu>
9:39 AM Wednesday, March 15, 2017
to me
Good morning,
Dr. Otiko has been invited to present his poster during the poster session at DFCon. This is a formal session, but it is not an exclusive speaking event.
Poster session will take place on March 24 from 11:40 am to 2:20 pm.
With kind regards,
Joanna Starosolska
Administrative Secretary
Division of Vascular Surgery
Baylor College of Medicine
One Baylor Plaza, MS 390
Houston, TX 77030
Ph: 713-798-7851
Fx: 713-798-2744
DFCon 2017
cid:image004.jpg@01D12770.3F6AF690
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
dfcon.com/
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
February 8, 2017
~ CEO speaking at the Global Diabetic Foot Conference in Houston March 23-25, 2017 ~
http://www.marketwired.com/press-release/dr-chris-ayo-otiko-president-viaderma-inc-is-selected-write-article-healing-diabetic-otc-pink-vdrm-2194656.htm
https://www.drugs.com/otc/676986/viabecline.html
https://www.linkedin.com/pulse/healing-diabetic-ulcers-dave-pozek-1
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129403043
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129390203
message_id=129040891
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128962099
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
February 3, 2017
~ MASSIVE sales coming.. 500,000 units x $125 = $62,500,000 in 2017~
http://www.marketwired.com/press-release/viaderma-inc-targets-online-sales-wound-care-centers-distribution-companies-its-viabecline-pinksheets-vdrm-2193323.htm
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129402236
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129339194
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129286070
January 11, 2017
~Filed a patent application with the USPTO for its proprietary innovative transdermal delivery system~
http://www.marketwired.com/press-release/viaderma-incs-ceo-files-new-patent-application-signs-two-licensing-deals-locates-product-otc-pink-vdrm-2187878.htm
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129386093
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129283860
November 30, 2016
"Patent Pending Transdermal System" can deliver medications and nutrients into the body through the skin. The solution combined with FDA registered drugs can increase the absorption as much as 100 times directly to the localized treatment areas,
http://www.marketwired.com/press-release/viaderma-inc-clinical-studies-abroad-europe-middle-east-asia-show-promising-results-otc-pink-vdrm-2179850.htm
November 14, 2016
Filed Patent Pending use of its innovative transdermal system for the delivery of (CBD's) Calanoids and (THC) Tetrahydrocannabinol for the treatment of several diseases
http://www.marketwired.com/press-release/viaderma-inc-enters-mmj-medical-marijuana-industry-with-patent-pending-cbd-delivery-otc-pink-vdrm-2175498.htm
VDRM ~ DOCS from all over the world will hear about ViaDerma!
Starosolska, Joanna <Joanna.Starosolska@bcm.edu>
9:39 AM Wednesday, March 15, 2017
to me
Good morning,
Dr. Otiko has been invited to present his poster during the poster session at DFCon. This is a formal session, but it is not an exclusive speaking event.
Poster session will take place on March 24 from 11:40 am to 2:20 pm.
With kind regards,
Joanna Starosolska
Administrative Secretary
Division of Vascular Surgery
Baylor College of Medicine
One Baylor Plaza, MS 390
Houston, TX 77030
Ph: 713-798-7851
Fx: 713-798-2744
DFCon 2017
cid:image004.jpg@01D12770.3F6AF690
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
dfcon.com/
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
February 8, 2017
~ CEO speaking at the Global Diabetic Foot Conference in Houston March 23-25, 2017 ~
http://www.marketwired.com/press-release/dr-chris-ayo-otiko-president-viaderma-inc-is-selected-write-article-healing-diabetic-otc-pink-vdrm-2194656.htm
https://www.drugs.com/otc/676986/viabecline.html
https://www.linkedin.com/pulse/healing-diabetic-ulcers-dave-pozek-1
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129403043
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129390203
message_id=129040891
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128962099
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
February 3, 2017
~ MASSIVE sales coming.. 500,000 units x $125 = $62,500,000 in 2017~
http://www.marketwired.com/press-release/viaderma-inc-targets-online-sales-wound-care-centers-distribution-companies-its-viabecline-pinksheets-vdrm-2193323.htm
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129402236
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129339194
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129286070
January 11, 2017
~Filed a patent application with the USPTO for its proprietary innovative transdermal delivery system~
http://www.marketwired.com/press-release/viaderma-incs-ceo-files-new-patent-application-signs-two-licensing-deals-locates-product-otc-pink-vdrm-2187878.htm
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129386093
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129283860
November 30, 2016
"Patent Pending Transdermal System" can deliver medications and nutrients into the body through the skin. The solution combined with FDA registered drugs can increase the absorption as much as 100 times directly to the localized treatment areas,
http://www.marketwired.com/press-release/viaderma-inc-clinical-studies-abroad-europe-middle-east-asia-show-promising-results-otc-pink-vdrm-2179850.htm
November 14, 2016
Filed Patent Pending use of its innovative transdermal system for the delivery of (CBD's) Calanoids and (THC) Tetrahydrocannabinol for the treatment of several diseases
http://www.marketwired.com/press-release/viaderma-inc-enters-mmj-medical-marijuana-industry-with-patent-pending-cbd-delivery-otc-pink-vdrm-2175498.htm
DOCS from all over the world will hear about ViaDerma!
Starosolska, Joanna <Joanna.Starosolska@bcm.edu>
9:39 AM Wednesday, March 15, 2017
to me
Good morning,
Dr. Otiko has been invited to present his poster during the poster session at DFCon. This is a formal session, but it is not an exclusive speaking event.
Poster session will take place on March 24 from 11:40 am to 2:20 pm.
With kind regards,
Joanna Starosolska
Administrative Secretary
Division of Vascular Surgery
Baylor College of Medicine
One Baylor Plaza, MS 390
Houston, TX 77030
Ph: 713-798-7851
Fx: 713-798-2744
DFCon 2017
cid:image004.jpg@01D12770.3F6AF690
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
http://dfcon.com/
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
February 8, 2017
~ CEO speaking at the Global Diabetic Foot Conference in Houston March 23-25, 2017 ~
http://www.marketwired.com/press-release/dr-chris-ayo-otiko-president-viaderma-inc-is-selected-write-article-healing-diabetic-otc-pink-vdrm-2194656.htm
https://www.drugs.com/otc/676986/viabecline.html
https://www.linkedin.com/pulse/healing-diabetic-ulcers-dave-pozek-1
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129403043
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129390203
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129368069
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129334996
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129312100
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129311752
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129297007
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129296364
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129295215
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129286262
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129196331
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129040891
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128962099
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128961948
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128957163
Next week will be BIG. Mark this post.
Long $VDRM
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
https://www.linkedin.com/in/ivanklarich/
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
Braden32601 Friday, 03/10/17 10:45:58 PM
Re: touchscreen post# 14647
Post # of 15530
Just Good news about PATENTS & IR CONTACT>>
From VDRM IR >> "As for the patents, they were filed as provisional patents in December. I do not have the patent numbers but I will see if I can get them and send them to you. It usually takes a couple of months for the USPTO to show newly filed patents on their website, so they may or may be showing just yet, but will be very soon if they are not. I will get back to you shortly."
Please feel free to reach out anytime. Our new investor relations phone number is below. Thanks again for your support.
Investor Relations
(310) 734 6111
IR can be reached at the above Phone number, or by email: info@viadermalicensing.com
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
Danorocket Member Level Friday, 03/10/17 03:27:06 PM
Re: None
Post # of 15530
The IR I posted and answered within an hour
The original email was sent to info@viadermalicensing.com
Investor Relations
(310) 734 6111
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
ddtburg Friday, 03/10/17 01:04:24 PM
Re: A deleted message
Post # of 15530
GREAT to see the Doc got some help. He has much more to do than reply to request after request over things that have been gone over time and time again. This is becoming a true company instead of a one may show as it once was. For those of you that say it's his job I will reply NO it is not the CEOs job of any company to reply to investor requests. That's what they hire PR people to do........Now he can work on the guts of what this company is about...... Roll Doc Roll
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
Danorocket Member Level Friday, 03/10/17 12:55:28 PM
Re: None
Post # of 15530
Another Response:
MY Email back:
On Fri, 10 Mar, 2017 at 12:00 PM,
To: info@viadermalicensing.com
Wow! Thank you so much for the return info. Doing my own DD to insure and protect my investment. This seems like a great thing having family affected by some of the diseases Viaderma is working on.
Thank you!
RESPONSE:Fri 3/10/2017 12:48 PM
My pleasure, That's what we are here for. I checked on the patent numbers we will be publishing them very soon. Will probably put them up on our website. Please stay tuned.
Thanks
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
heintz Thursday, 03/09/17 12:23:26 AM
Re: Tradingtrader01 post# 14218
Post # of 15530
Love the PR. Obviously our DR has spent most of his life creating medicines with little knowledge of being a marketer and , with respect, businessman. Bringing on someone with experience like this should calm the nerves of any of the ones that were nervous about his lack of Business skills. We now have a DR who is at the top of his game partnered with a Businessman who is at the top of his game... Double Trouble.
NOW THE GOOD DOCTOR CAN FOCUS ON BEING A DOCTOR AND SOMEONE ELSE WILL BE HANDLING MOST OF THE BUSINESS. Think we can expect a more consistent PR release moving forward
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
nsomniyak Member Level Wednesday, 03/08/17 07:21:03 PM
Re: mylar23 post# 14177
Post # of 15530
I can't comment on this guy's credentials.
I will, however, state with certainty that you don't hire a "go to market" specialist unless you actually intend to bring something to he market and sell it.
In a small way this signals that VDRM is working to deploy the organizational infrastructure and grow the organizational capability it will need to sell its products. That is a good thing. "If you build it, they will come" only works in the movies.
Call the IR department and PLEASE post what they tell you here. We'd all love to hear what the company's plans are.
March 8, 2017
~ Sales, labeling & marketing being launched!! Industry expert hired!! ~
http://www.marketwired.com/press-release/viaderma-inc-hires-product-rollout-expert-manage-quality-control-labeling-marketing-pinksheets-vdrm-2201662.htm
~Ivan Klarich Reviews~
https://www.linkedin.com/in/ivanklarich/
Aidan Roark Makepeace
Founder/CEO at WRKPRTY
Aidan Roark worked with Ivan in different groups
I have had the privilege of working with and for Ivan on several software development and business strategy projects ranging from the start-up to the enterprise level and can say, without reservation, Ivan is amazing to work with. Ivan is a thoughtful and inspiring leader and team-builder, and an energetic, diligent, and reliable visionary in strategic planning and operations/executive management. I welcome every opportunity to work with Ivan and can wholeheartedly recommend his services, as well as those of his extensive team of associates.
Mireille Buiel
HR Lead at FindHotel
Mireille worked with Ivan but at different companies
I have worked together with Ivan as consultants at a California based FMCG manufacturing company. I got to know him as a value-based strategic thinker that keeps his eye on the long-term goal. He is able to bring teams and entrepreneurs quickly to the ‘pain points’ and find new practical solutions for their business (model) issues. I would definitely recommend him for complex organizational and commercial challenges.
John Fanaris
Co-Owner/GM/Sommelier at Rustic Kitchen
John worked with Ivan but at different companies
Preparing for growth and putting the right pieces together are crucial to success and Ivan brings the tools needed to the table. He has a non-confrontational demeanor in his analysis of your internal methodology with the uncanny knack of straight forward communication and a tell-it-like-it-is constructive advice. He is an expert at analyzing company operations and culture to develop a comprehensive strategy to reach your goals. If you are looking to take your company to the next level, Ivan is your man.
Jackie Lapin / Authors, Speakers, Get Leads, Get Booked
?? AUTHORS & SPEAKERS, GET LEADS, GET BOOKED–Book Your Own Speaking Engagements at Transformational Venues & Events
Jackie Lapin / worked with Ivan but at different companies
Ivan is one of the most brilliant forward-thinking business visionaries I've ever encountered. That skill is anchored by real world practical strategic analytics and implementation that ensures success. I want him on my team whenever I'm launching something new, improve what's already working or need to fix something that's not!
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129418493
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129409088
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129402020
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129401494
http://www.hopedance.org/home/awakenings/2920-virtual-realty-enters-the-arena-to-help-people-overcome-their-co-dependency-on-outside-approval-to-achieve-an-emotionally-free-high-performance-happy-life
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129344707
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129339497